PapersPMID:25618800
Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis.
- 01 · finding
- 1
- 02 · compound
- 1
- 03 · endpoint
- 1
- 04 · null
- 0
curcuminWhat moved
1 findingHow to read these marks →curcumin — decreases C-reactive protein concentration
very limitedFindingreplicated ×5
“Quantitative data synthesis revealed a significant effect of curcuminoids vs. placebo in reducing circulating CRP concentrations (weighed mean difference: -2.20 mg/L; 95% confidence interval [CI]: -3.96, -0.44; p = 0.01).”
Quoted verbatim from Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. - Study
- meta-analysis
- Effect
- −2.2 mean difference, 95% CI −3.96 to −0.44
- Population
- meta-analysis of randomized controlled trials of curcuminoids measuring circulating CRP concentration
Study record
- Read under
- curcumin
- Design
- randomised controlled trial
- Species
- human
- Population
- adults with metabolic syndrome (NCEP-ATPIII criteria)
- Participants
- 117
- Comparator
- placebo
- Duration
- 56 days
- Endpoints measured
- 4
- Record
- extracted
- Readings recorded
- 2